Fundraising Fox
Resolve Nanotherapeutics
1 known investors
Find your way into Resolve Nanotherapeutics
Sign up to see every warm intro you have to Resolve Nanotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resolve Nanotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.
Investors · 1
Frequently asked questions
- What does Resolve Nanotherapeutics do?
- Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.
- Who are Resolve Nanotherapeutics's investors?
- Resolve Nanotherapeutics's investors include Innovation UBC.